Phrenic Nerve Stimulation for Central Sleep Apnoea: When and Why?

Area of Science:

• Respirology
• Neurology
• Sleep Medicine

Background:

• Central sleep apnoea (CSA) is a sleep disorder characterized by absent respiratory effort due to respiratory control instability.
• Current treatments like positive airway pressure and medications are often ineffective for many patients.
• Phrenic nerve stimulation is an emerging therapy for refractory moderate to severe CSA.

Purpose of the Study:

• To provide a comprehensive review of central sleep apnoea (CSA).
• To explore the pathophysiology and conventional treatments for CSA.
• To examine the efficacy and limitations of phrenic nerve stimulation for CSA.

Main Methods:

• Literature review of current scientific publications.
• Analysis of studies on phrenic nerve stimulation devices, including the remedē System.
• Evaluation of treatment outcomes and patient responses.

Main Results:

• Phrenic nerve stimulation demonstrates efficacy in managing moderate to severe CSA.
• The remedē System is an evidence-based device for this therapeutic approach.
• Understanding CSA pathophysiology is crucial for optimizing treatment.

Conclusions:

• Phrenic nerve stimulation is a viable therapeutic option for refractory central sleep apnoea.
• Further research is needed to fully understand the long-term efficacy and limitations.
• This approach offers hope for patients with limited treatment alternatives.